hold on there's just too much going on in Congress lmao...
Protects pharmacists refusing to dispense abortion-inducing drugs due to religious beliefs.
Rep. Burchett
In committee, no House vote yet
This bill, introduced by Representative Burchett, aims to protect pharmacists who, due to their sincerely held religious beliefs, choose not to dispense or sell certain abortion-inducing medications. It explicitly states they cannot be punished, like losing their license or federal funding, for this decision. The bill has been referred to the House Energy and Commerce Committee, where it will be reviewed before potentially moving to a full House vote.
Introduced Apr 20, 2026
This bill is currently in the Committee stage, specifically the House Committee on Energy and Commerce. It was introduced on April 20, 2026. For it to become law, the committee must approve it, then it needs to pass a vote in the House of Representatives, then pass in the Senate, and finally be signed by the President.
If this bill becomes law, pharmacists across the U.S. could legally decline to dispense or sell medications like mifepristone and misoprostol, specifically for abortion services, if it goes against their religious beliefs. They would be protected from any professional consequences, including license revocation or losing federal funding. For individuals, this means that obtaining these specific medications might become more challenging, potentially requiring visits to multiple pharmacies to find one willing to dispense them.
Supporters Say
Supporters argue the bill protects pharmacists' religious freedom and conscience rights in their workplace.
Critics Say
Critics may argue the bill could restrict access to legally prescribed medications and create barriers to healthcare.
Those in favor of the bill believe it upholds the fundamental right to religious freedom, ensuring that professionals are not forced to act against their deeply held convictions. They contend that pharmacists should not be penalized for exercising their conscience. Conversely, opponents might raise concerns about patient access to necessary medical care, arguing that such refusals could delay or deny important medications, particularly in areas with limited pharmacy options.